dcsimg Emerging Roles for the Respiratory Therapist in Alpha-1 Antitrypsin Deficiency | AARC.org

Emerging Roles for the Respiratory Therapist in Alpha-1 Antitrypsin Deficiency

Alpha-1 Foundation
Sponsored in part by an unrestricted educational grant from Alpha-1 Foundation

This course was developed at the request of our membership and is presented by a group of physicians who are internationally recognized in the identification and management of Alpha-1 Antitrypsin Deficiency. This course is presented by the American Association for Respiratory Care and sponsored in part by an unrestricted educational grant from the Alpha-1 Foundation.

Course Modules

Presenters

Pricing

Continuing Respiratory Care Education (CRCE®) Credits

At the conclusion of the course, you will have the opportunity to earn 3 CRCE credits by taking an exam. The exam relates to the content presented and awards CRCE credits after you pass this exam. You will have two opportunities to pass the exam and earn CRCE credits for viewing this course. You must pass the exam in order to obtain a certificate for taking this online course.

Requirements

Note

When you register for this course, your email address will also be provided to the Alpha-1 Foundation for follow-up. The AARC will be in contact with you in the future to ask you to take a brief online survey to find out how many COPD patients you identified to consider enrolling in an Alpha-1 Antitrypsin Coding Trial.

Emerging Roles for the Respiratory Therapist in Alpha-1 Antitrypsin Deficiency

Earn 3.0 CRCE credits after passing the accompanying test

Go to AARC University to purchase this course and access course materials

Conflict of Interest/Commercial Support Statement
None of the planners, faculty or their spouses has any relationships with pharmaceutical companies, biomedical device manufacturers and/or corporations whose products or services are related to pertinent therapeutic areas. Off-label: (using products for a purpose other than that for which it was approved by the Food and Drug Administration) use will not be discussed in this course. This educational activity has not received commercial support.